These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 375794)

  • 1. Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
    Schilsky RL; Anderson T
    Ann Intern Med; 1979 Jun; 90(6):929-31. PubMed ID: 375794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin.
    Lam M; Adelstein DJ
    Am J Kidney Dis; 1986 Sep; 8(3):164-9. PubMed ID: 3752072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting.
    Bell DR; Woods RL; Levi JA
    Eur J Cancer Clin Oncol; 1985 Mar; 21(3):287-90. PubMed ID: 4040020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and hypomagnesemia.
    Lajer H; Daugaard G
    Cancer Treat Rev; 1999 Feb; 25(1):47-58. PubMed ID: 10212589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium homeostasis following chemotherapy with cisplatin: a prospective study.
    Stewart AF; Keating T; Schwartz PE
    Am J Obstet Gynecol; 1985 Nov; 153(6):660-5. PubMed ID: 4061536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
    Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
    Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetany in children treated with cisplatinum.
    Welch RJ; Pearson AD; Craft AW
    Pediatr Hematol Oncol; 1987; 4(2):167-70. PubMed ID: 3152923
    [No Abstract]   [Full Text] [Related]  

  • 8. Platinum nephrotoxicity.
    Madias NE; Harrington JT
    Am J Med; 1978 Aug; 65(2):307-14. PubMed ID: 99034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-platinum-induced renal sodium wasting.
    Lammers PJ; White L; Ettinger LJ
    Med Pediatr Oncol; 1984; 12(5):343-6. PubMed ID: 6541750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced renal toxicity magn…ified: role of magnesium deficiency in AKI onset.
    Romani AM
    Am J Physiol Renal Physiol; 2015 Dec; 309(12):F1005-6. PubMed ID: 26511648
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal tubular function in patients treated with high-dose cisplatin.
    Daugaard G; Abildgaard U; Holstein-Rathlou NH; Bruunshuus I; Bucher D; Leyssac PP
    Clin Pharmacol Ther; 1988 Aug; 44(2):164-72. PubMed ID: 2840230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil.
    Evans TR; Harper CL; Beveridge IG; Wastnage R; Mansi JL
    Eur J Cancer; 1995; 31A(2):174-8. PubMed ID: 7718321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury.
    Alves SC; Tomasi CD; Constantino L; Giombelli V; Candal R; Bristot Mde L; Topanotti MF; Burdmann EA; Dal-Pizzol F; Fraga CM; Ritter C
    Nephrol Dial Transplant; 2013 Apr; 28(4):910-6. PubMed ID: 22764195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trial.
    Martin M; Diaz-Rubio E; Casado A; López Vega JM; Sastre J; Almenarez J
    Am J Clin Oncol; 1992 Aug; 15(4):348-51. PubMed ID: 1514533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The familial magnesium-losing kidney.
    Hedemann L; Strunge P; Munck V
    Acta Med Scand; 1986; 219(1):133-6. PubMed ID: 3953313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomagnesemia following high-dose intracavitary cisplatin with systemically administered sodium thiosulfate.
    Markman M; Cleary S; Howell SB
    Am J Clin Oncol; 1986 Oct; 9(5):440-3. PubMed ID: 3776908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal tubular dysfunction following cis-dichlorodiammine platinum therapy.
    Davis S; Kessler W; Haddad BM; Maesaka JK
    J Med; 1980; 11(2-3):133-41. PubMed ID: 6931873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue injury and proliferative response induced in rat kidney by cis-diamminedichloroplatinum (II).
    Laurent G; Yernaux V; Nonclercq D; Toubeau G; Maldague P; Tulkens PM; Heuson-Stiennon JA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(3):129-45. PubMed ID: 2899921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening hypocalcemia and hypomagnesemia associated with cisplatin chemotherapy.
    Gonzalez C; Villasanta U
    Obstet Gynecol; 1982 Jun; 59(6):732-4. PubMed ID: 7200596
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypomagnesemic hypocalcemia secondary to renal magnesium wasting.
    Bar RS; Wilson HE; Mazzaferri EL
    Ann Intern Med; 1975 May; 82(5):646-9. PubMed ID: 1137260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.